News & Updates

Dermatological adverse events (dAEs) associated with apalutamide, though common, can be managed with topical steroids with or without oral antihistamines, reports a study.

When considering concurrent chemoradiotherapy (CCRT) in the treatment of patients with esophageal squamous cell carcinoma (ESCC), the 60 Gy dose yields similar survival outcomes but a higher incidence of severe pneumonitis when compared with the lower 50 Gy dose, according to the results of a phase III study.

Breast arterial calcification (BAC), as viewed on screening mammograms, may suggest a risk of cardiovascular disease (CVD) in postmenopausal women, a recent US-based study showed.

The addition of toripalimab to first-line chemotherapy led to significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced non-small cell lung cancer (NSCLC) without EGFR/ALK mutations, according to the updated results of the CHOICE-01* trial presented at the ASCO Plenary 2022.

Sentinel lymph node (SLN) biopsy for early oral cavity cancer is likely to yield a false negative result when the number of SLNs is small, a recent study has found.